Last Updated on December 31, 2023 by The Health Master
Natco Pharma on Friday said marketing partner Breckenridge Pharmaceutical Inc. has launched 10 mg strength of Everolimus Tablets (generic for Afinitor) in the US market.
The drug is used in the treatment of certain cancer. USFDA had previously granted final approval for this ANDA.
The 10mg strength of Afinitor had generated annual sales of $392 million during the twelve months ending July 2021, it said citing industry sales data.
Breckenridge launched Everolimus tablets 2.5mg, 5mg and 7.5mg strengths during the first quarter of 2021 in the US., the company said in a release.
Lupin launches Droxidopa capsules
Sun Pharma launches a novel formulation for Cough management
Lincoln Pharma plans to launch Cephalosporin products
Natural Antioxidant Gamma Oryzanol launched in India
Dr. Reddy’s Labs launches Rx drug Minoxidil for treatment of hair
Dr Reddy’s launches Reddy-Lenalidomide
Woman held for selling fake Cancer Drugs
FDA advisers to review C-19 shots for young kids
New drug combination found effective against C-19 infection: Study
Drug recall: Auro Pharma recalls Drug used to treat severe disease
Govt to introduce needle free Vaccine shortly
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
